Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks

Journal:
Nature Medicine
Published:
Affiliations:
31
Authors:
29
Institutions Authors Share
Washington University in St. Louis (WUSTL), United States of America (USA)
10.000000
10.000000
0.34
AbbVie, United States of America (USA)
3.000000
0.10
Johnson & Johnson, United States of America (USA)
2.000000
0.07
Takeda Pharmaceuticals U.S.A., Inc., United States of America (USA)
2.000000
0.07
Biogen, United States of America (USA)
2.000000
0.07
Foundation for the National Institutes of Health (FNIH), United States of America (USA)
2.000000
0.07
Northern California Institute for Research and Education (NCIRE), United States of America (USA)
1.000000
0.03
University of California, San Francisco (UCSF), United States of America (USA)
1.000000
0.03
Alzheimer's Association, United States of America (USA)
1.000000
0.03
University of Pennsylvania (Penn), United States of America (USA)
1.000000
0.03
Indiana University (IU), United States of America (USA)
1.000000
0.03
University of Wisconsin-Madison (UW-Madison), United States of America (USA)
0.666667
0.02
Rush University Medical Center, United States of America (USA)
0.500000
0.02
Sahlgrenska Academy, GU, Sweden
0.500000
0.02
Banner Alzheimer's Institute, United States of America (USA)
0.333333
0.01
Banner Sun Health Research Institute, United States of America (USA)
0.333333
0.01
Sahlgrenska University Hospital (SU), GU, Sweden
0.166667
0.01
UK DRI at UCL (UK DRI UCL), United Kingdom (UK)
0.166667
0.01
UCL Queen Square Institute of Neurology, United Kingdom (UK)
0.166667
0.01
The Hong Kong University of Science and Technology (HKUST), China
0.166667
0.01